Impulsiveness in children with attention-deficit/hyperactivity disorder after an 8-week intervention with the Mediterranean diet and/or omega-3 fatty acids: a randomised clinical trial
Patients in Waukesha should remain on the lookout for announcements concerning Retatrutide's availability, and if applicable to their needs, inquire about how to get Retatrutide once it's approved
Date: January 23, 2026 Introduction In the high-stakes arena of metabolic medicine, few companies have generated as much speculative fervor and clinical awe as Viking Therapeutics (NASDAQ: VKTX)
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication A preclinical pharmacokinetic in-vivo study has been conducted in which the AmorphOX technology was used to develop three powder-based intranasal formulations with semaglutide, which were compared with an oral and an injectable formulation
One such medication is Semaglutide GLP-1, a unique weight loss medication that works differently than others in its category
CERTIFIED CARE FOR YOUR SKIN: Dermatologically Tested